Mutations in ARID1a have been identified in multiple human carcinomas [5–9] at an alarmingly high incidence, and recently compared to the mutation frequency of the P53 gene (TP53) which is the most commonly altered gene in human carcinomas [10, 11]. This evidence concerns the gene TP53 and carcinoma.